Delivery Order SPE2DB22D1106-SPE2DB25FFAZ8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a contract ceiling value of $11,511.90. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- This delivery order, awarded on July 23, 2025, procures Provocholine inhalation solution in 18ML pack quantities for the Defense Department's Medical Supply Chain with a ceiling value of $6,732.76. The award is issued under firm fixed pricing with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected as the awardee through competitive procurement with no set-aside designation. This delivery order is issued as a...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $7,077.65, is for the supply of Provocholine inhalation solution. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which supports the provision of a wide range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Provocholine Inhalation Solution in 18 mL packs. The order has a ceiling value of $3,166.13 and is a firm-fixed price contract with an ultimate completion date of August 5, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued up...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,120.45 firm fixed price delivery order is for the supply of Provocholine inhalation solution, a medical product used for diagnostic purposes. The contract has a completion date of July 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of a pharmaceutical product, Provocholine Inhalation Solution, valued at $1,173.82. The contract has a firm fixed price and an ultimate completion date of September 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medical product to support the healthcare needs of military treatment...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Provocholine Inhalation Solution in 18 mL packs. The contract is a firm-fixed-price delivery order with a ceiling value of $3,339.22 and a performance period through March 3, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order valued at $4,265.39 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the provision of Provocholine Inhalation Solution, a pharmaceutical product, with a period of performance extending through June 2025. The contract does not have a set-aside designation, indicating it was open to full and open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,136.52 firm fixed-price contract is for the supply of 4565334260 - Provocholine Inhalation Solution Packs (18mL). The contract has an ultimate completion date of August 5, 2024 and was awarded on August 2, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,572.10 firm-fixed-price contract is for the supply of Provocholine 100 mg vials, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for the provision of a comprehensive range of...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAZ8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,642.65 to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ml pack configuration. The contract, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement and regularly supplies pharmaceuticals and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded delivery orders across multiple therapeutic domains. Provocholine is a pharmaceutical used for bronchial challenge testing in pulmonary diagnostics, representing specialized medical commodities typical of the company's supply portfolio to support military medical operations and readiness worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/1/25 |